Recent studies suggest that preneural type I (glomus) cells in the arterial chemoreceptor tissue of the carotid body act as primary transducer elements which respond to natural stimuli (low 02, pH or increased CO2) by releasing chemical transmitter agents capable of exciting the closely apposed afferent nerve terminals. These type I cells contain multiple putative transmitters, but the identity of the natural excitatory agents remains an unresolved problem in carotid body physiology. Characterization of putative transmitter involvement in the response to natural and pharmacological stimuli has therefore become fundamental to further understanding of chemotransmission in this organ. The present study demonstrates that a natural stimulus (hypoxia) evokes the release of dopamine (DA) and norepinephrine (NE) in approximate proportion to their unequal stores in rabbit carotid body (DA release/NE release = 8.2). In contrast, nicotine (100/~M), a cholinornimetic agent thought to act on the nicotinic receptors present on the type I cells, evokes the preferential release of NE (DA release/NE release = 0.17). These findings suggest that distinct mechanisms are involved in a differential mobilization of these two cateeholamines from the rabbit carotid body.
The chemosensory tissue of the mammalian carotid body consists of morphologically distinct type I (glomus) cells which lie in synaptic association with afferent nerve terminals of the carotid sinus nerve (CSN), a branch of the glossopharyngeal (IXth) cranial nerve. A fundamental issue in carotid body physiology concerns the role played by type I cells in chemotransduction and chemotransmission of natural and pharmacological stimuli (low pO2, pH or elevated pCO2; and cholinergic, peptidergic and catecholaminergic agents) 1~. With respect to chemotransduction, previous studies have demonstrated that type I cells respond to natural stimuli in vivo and in vitro in the absence of innervation 1°, thus implying that these cells may be good candidates for the role of chemosensory transducer in the carotid body. Moreover, recent reports have shown that type I cells possess a unique O2-sensitive potassium conductance, which is decreased by hypoxic stimuli within the physiological range 2~. With respect to chemotransmission between type I cells and sensory nerve terminals, a major problem remains how the multiple putative neurotransmitters found in type I cells (including biogenic amines and neuroactive peptides) are able to interact in the initiation and modulation of the chemosensory discharge of the CSN.
The putative transmitters present in highest concentrations in the carotid body are the catecholamines dopamine (DA) and norepinephrine (NE) . While the precise role of DA remains uncertain, it is clear from previous studies with the rabbit carotid body that the synthesis and release of DA by type I cells is increased by natural stimuli 1°'11, and that dopaminergic (Dz) receptors are present on CSN afferents 5'24. In contrast, virtually nothing is known regarding the regulation of NE metabolism in the organ, and although its synthetic enzyme (dopamine fl-hydroxylase; DBH) is known to be present in type I cells 2'27, attempts to demonstrate NE/DBH sensitivity to chemoreceptor stimuli have until very recently met with little success 14'15'26. Likewise, while the results of pharmacological experiments suggest that certain chemoreceptor responses by the carotid body may be mediated by fl-adrenergic receptors a2, a mechanism coupling specific stimuli to NE turnover and utilization has yet to be demonstrated.
In Rabbit carotid bodies were first chronically sympathectomized to eliminate the sympathetic (NE-containing) nerve terminals from the carotid body. Under pentobarbital anesthesia (35 mg/kg), superior cervical sympathetic ganglia were bilaterally excised from adult New Zealand white rabbits 10-14 days prior to experimentation, at which time the animals were re-anesthetized and their carotid bodies surgically removed and cleaned of adjoining connective tissue in a bath of ice-cold modified Tyrode's solution (in mM: NaCI 112, KCI 4.7, CaCI 2 2.2, MgCI 2 1.1, sodium glutamate 42, HEPES buffer 5, glucose 5.6, pH = 7.42) equilibrated with 100% 0 2 . The tissues were pooled and incubated for 2 h, as previously described 9, in media containing [3H]tyrosine Ci/mmol; 20-25 /tM; Amersham) plus ascorbic acid (100/~M) and tyrosine hydroxylase cofactor (6-MPH4; 50/~M). Following incubation, carotid bodies were separated into groups of 2-4 and washed for 90 min (fresh media every 30 min) in standard scintillation vials containing modified Tyrode's solution equilibrated with 100% 0 2. Catecholamine (CA) release was determined utilizing radiolabeling techniques in conjunction with HPLC separation of DA from NE, and was assessed during stimulus cycles which each consisted of sequential control (100% O2-media ), stimulus (low 0 2-or nicotine-containing media) and post-stimulus (100% O2-media ) periods. Similar results to those reported here were obtained when a bicarbonate-CO 2 (95% 02/5% CO2, pH = 7.42) buffer was used in place of the HEPES-O 2 (100% 0 2 o r 10% 02/90% N2) buffer; i.e., release profiles were qualitatively the same, and quantitatively within 10% of each other. Superfusates were collected in vials containing ascorbic acid (10 mM), plus acetic acid (4 M), and stored overnight (4 °C).
[3H]DA, [3H]DOPAC and [3H]NE were eluted from alumina columns (see ref. 10 ) with 1 N perchloric acid, and the labeled products combined with unlabeled NE, DA and DOPAC prior to HPLC separation on a C-18 reverse phase column (Rainin) in phosphate-buffered mobile phase. Sample aliquots spiked with 3,4-dihydroxymandelic acid (DOMA) and 3-methoxy-4-hydroxy-phenylglycol (MHPG) were chromatographed separately to quantify these NE metabolites. CA was detected electrochemically with an ESA Coulochem (Model 5100A; 5021 conditioning cell; 5011 analytical cell) in the reductive mode. Peaks of interest were collected automatically with a Gilson Model 202 fraction collector for subsequent counting in a Packard Model 1500 scintillation spectrometer.
The data presented in Fig. 1 (top) show total [3H]CA release from an experiment in which carotid bodies were 161 exposed to two stimulus cycles; the first cycle contained media equilibrated with 10% 02, the second cycle contained 100% 02 equilibrated media along with 100 /tM nicotine, which in preliminary dose-response experiments had proven to evoke an intermediate amount of [3H]CA release. Between stimulus cycles the tissue was washed for 30 min with two changes of 100% 02-equilibrium media. We consistently observed a different time course of CA release for low 0 2 vs nicotine stimulation. CA release evoked by low 0 2 persisted into the first post-stimulus period, whereas nicotine-evoked release ended abruptly after the 5 min stimulus period. Reversal of the stimulus order resulted in similar relative patterns of CA release by low 0 2 and nicotine. The reasons for this difference in time course of release is not known, but receptor desensitization by nicotine 2°'22 must be considered a possible explanation for future experiments addressing this issue. The receptor specificity of the nicotine effect was established in control experiments which showed that mecamylamide (100 ~M), hexamethonium (100 ktM) and (+)-tubocurarine (50 ~M) blocked more than 95% of the nicotine-evoked release of [3HICA. Fig. 1 (bottom) shows the relative proportions of DA and NE released during the two stimulus cycles described above. Table II . The data show that conversion from dpm released/mg tissue, to absolute amount released (pmoi/mg tissue) confirms the predominance of DA release by hypoxia and actually exaggerates the predominance of NE release by nicotine. The absolute amounts of NE and DA released in response to hypoxia were approximately in proportion to the relative content of these two CA in the tissue, whereas in response to nicotine the nearly 5-fold preference for NE release reflects a markedly disproportionate mobilization of NE vs DA stores in these sympathectomized carotid bodies. The data additionally show that basal release consisted of Table I ). In this regard, it may be important to consider that release-promoting events might be occurring secondary to the initial stimulus-induced release; for example, the activation of fl-adrenergic receptors in the carotid body has been reported to evoke DA outflow 25, and consequently a possible sequence of events might involve first a selective nicotine-induced release of NE, followed by fl-receptor activation and the subsequent release of DA. In addition, preliminary experiments which examined the effects of combined stimulation with nicotine and hypoxia showed that the total [3H]CA release was larger than the sum of the release evoked by each condition, suggesting interesting interactive effects of these stimuli.
The observation that hypoxia and nicotine evoke the release of DA and NE from the carotid body in distinctly different proportions suggests that these stimuli activate diverse mechanisms for mobilizing these two CA from the type I cells of this chemosensory organ. Although it has been conjectured that separate dopaminergic and noradrenergic cells may exist in the carotid body 1, 2,4,16,17.23, recent immunocytochemical studies have shown that virtually all type I cells contain both tyrosine hydroxylase (TH), the rate limiting enzyme for CA synthesis, and dopamine-fl-hydroxylase (DflH), the synthetic enzyme for NE production 2'27. While these studies suggest a ubiquitous distribution for DA and NE amongst type I cells, the levels of immunocytochemical reaction product for DflH reported in these studies indicate that some cells may contain much more NE than others. This possibility, coupled with the observation by Chen and Yates I that specific a-bungarotoxin binding sites in the carotid body are restricted to a subgroup of type I cells (distinguished on the basis of dense-core vesicle size; refs. 16, 23) , suggests the possibility that the observed preferential release of NE over DA might arise from the selective distribution of nicotinic receptors on cells which contain relatively high levels of NE. Alternatively, type I cells in the carotid body may represent a homogeneous population with respect to their content of DA and NE and their sensitivity to nicotine. Different proportions of CA release would then be achieved through the selective mobilization of dense-cored vesicles containing either mostly DA or NE. The available data are equivocal with respect to the cellular mechanisms involved in the observed differential release of CA, and although recent immunocytochemical studies of TH and DflH have provided useful information in this regard, it must also be recognized that the demonstrated presence of a transmitter's synthetic enzymes do not necessarily signal the presence of the transmitter 19.
Finally, the involvement of nicotinic receptors in the response to type I cells to chemoreceptor stimuli (natural and pharmacological) suggests a role for ACh in chemosensation. More than 20 years ago, Eyzaguirre and Zapata s demonstrated that anoxia or electrical stimulation of the carotid body evoked the release of an ACh-like substance from the organ. Early neurochemical and autoradiographic studies placed ACh in the type I cells 1~, and this prospect was firmly established by recent immunocytochemical studies localizing to these cells the synthetic enzyme for ACh, choline acetyltransferase (CHAT) 28. Ligand binding studies using a-bungarotoxin and quinuclidinylbenzylate (QNB) have further demonstrated that cholinergic receptors are located on type I cells 6'7. The current demonstration that nicotinic receptors evoke the preferential release of NE from the carotid body emphasizes the need for further experimentation regarding the physiological roles played by ACh and NE in the carotid body.
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